PTC Therapeutics
PTCT
#2687
Rank
A$9.33 B
Marketcap
A$116.31
Share price
-0.76%
Change (1 day)
54.99%
Change (1 year)

PTC Therapeutics (PTCT) - Total debt

Total debt on the balance sheet as of September 2025 : A$0.61 Billion

According to PTC Therapeutics 's latest financial reports the company's total debt is A$0.61 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

PTC Therapeutics - Total debt on balance sheet (from 2012 to 2025)

Total debt by year

Year Total debt Change
2024-12-31A$3.97 B21.42%
2023-12-31A$3.27 B52.34%
2022-12-31A$2.14 B22.66%
2021-12-31A$1.75 B220.22%
2020-12-31A$0.54 B16.7%
2019-12-31A$0.46 B115.71%
2018-12-31A$0.21 B16.97%
2017-12-31A$0.18 B36.28%
2016-12-31A$0.13 B8.07%
2015-12-31A$0.12 B
2014-12-31N/A-100%
2013-12-31A$0.05 M-98.83%
2012-12-31A$4.69 M-58.78%
2011-12-31A$11.4 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Vertex Pharmaceuticals
VRTX
A$2.76 B 347.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
A$1.88 B 204.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
A$0.11 B-80.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
A$75.22 M-87.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A$0.10 B-83.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$48.20 B 7,707.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland